Highlights and Quick Summary
- Accrued Expenses for the quarter ending June 30, 2023 was $101 Million (a 29.07% increase compared to previous quarter)
- Year-over-year quarterly Accrued Expenses decreased by -14.86%
- Annual Accrued Expenses for 2022 was $123 Million (a -12.25% decrease from previous year)
- Annual Accrued Expenses for 2021 was $140 Million (a 6.77% increase from previous year)
- Annual Accrued Expenses for 2020 was $132 Million (a 29.05% increase from previous year)
Visit stockrow.com/EBS
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Accrued Expenses of Emergent Biosolutions Inc.
Most recent Accrued Expensesof EBS including historical data for past 10 years.Interactive Chart of Accrued Expenses of Emergent Biosolutions Inc.
Emergent Biosolutions Inc. Accrued Expenses for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | $100.8 | $78.1 | – | – | – |
| 2022 | $123.2 | $118.4 | $114.7 | $85.7 | $123.2 |
| 2021 | $140.4 | $116.3 | $97.0 | $80.0 | $140.4 |
| 2020 | $131.5 | $111.8 | $92.8 | $89.0 | $131.5 |
| 2019 | $101.9 | $107.6 | $99.5 | $86.5 | $101.9 |
| 2018 | $88.9 | $49.23 | $39.81 | $31.35 | $88.9 |
| 2017 | $42.7 | $36.54 | $26.2 | $27.66 | $42.7 |
| 2016 | $40.91 | $36.38 | $32.26 | $30.72 | $40.91 |
| 2015 | $38.21 | $34.3 | $32.76 | $25.42 | $38.21 |
| 2014 | $37.93 | $31.54 | $26.0 | $23.12 | $37.93 |
| 2013 | $25.87 | $19.78 | $16.55 | $13.19 | $25.87 |
| 2012 | $24.21 | $17.5 | – | – | $24.21 |
Business Profile of Emergent Biosolutions Inc.
Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic